IFN-α/anti-PD-L1 fusion protein activates tumor specific CD8(+) T lymphocyte responses for anti-tumor efficacy

IFN-α/anti-PD-L1 fusion protein activates tumor specific CD8(+) T lymphocyte responses for anti-tumor efficacy

YIN Zhi-wen, HOU Ji-yan, HAN Ping, et al

PDF(1026 KB)

Welcome to Current Immunology, Today is

PDF(1026 KB)

Current Immunology ›› 2019, Vol. 39 ›› Issue (1) : 1-7.

IFN-α/anti-PD-L1 fusion protein activates tumor specific CD8(+) T lymphocyte responses for anti-tumor efficacy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 39(1): 1-7

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1026 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉